Harvard Review of Psychiatry Instructions for Authors

HARVARD REVIEW OF PSYCHIATRY

INSTRUCTIONS FOR AUTHORS

The Harvard Review of Psychiatry is a bimonthly journal that publishes scholarly articles on a wide variety of topics

of interest to clinicians. It includes the following types of articles:

Reviews. Reviews summarize and synthesize the literature on various topics in a rigorous, scholarly, and

clinically relevant fashion. These topics may include psychotic disorders, mood disorders, personality disorders,

substance use disorders, anxiety disorders, neuroscience, child psychiatry, geriatric psychiatry, psychological

aspects of psychiatry, legal and policy issues in psychiatry, and other subjects relevant to clinicians.

Perspectives. Perspectives provide an overview of an area of interest to clinicians and in which there is

controversy or only limited literature. Authors should be experts who can provide both a synthetic review of the

existing literature and a particular clinical perspective derived from their expertise.

Columns. Columns present a well-argued, thoughtful point of view on a focused topic. They should cite relevant

literature that supports the author’s viewpoint, as well as literature that may conflict with it. Columns may

include clinical case material; for material based on actual cases, the appropriate patient consent form must be

submitted (see p. 9 for links to the required forms).

Clinical Challenges. Clinical Challenges present a clinical case report and are followed by expert discussion of

the case from multiple perspectives. These cases present diagnostic or treatment challenges, or highlight a

current debate in the field. Patient consent forms are required for clinical challenges (see p. 10 for links to the

required forms). Prior to manuscript preparation, prospective authors should contact Communications Editor,

Dawn Sugarman, PhD (email: dsugarma[email protected].edu).

Disruptive Innovation. Disruptive Innovation (DI) articles are brief essays wherein thought leaders propose novel

areas of inquiry or well-reasoned challenges to orthodoxy in any psychiatry-related research, practice, or policy area.

Although written within a scholarly framework, they also may reflect the author’s experience and may be presented in

the author’s own voice. DI essays will be promoted through Media Alerts and other social media upon their online

publication. Prospective authors of DI submissions are encouraged to contact Joshua Roffman, MD, MMSc

(jroffman@partners.org) prior to submission.

Length.

• Reviews, Perspectives, and Clinical Challenges should not exceed 6,000 words, excluding references,

tables, and figures.

• Columns should be approximately 3,000 words, excluding references, tables, and figures.

• Disruptive Innovation articles should be 1,500 words or less, with a maximum of 10 references and 1 table

or figure.

• Due to space constraints, for manuscripts with multiple tables and figures, we may only be able to print one

table or figure per manuscript. The remaining tables and figures will be printed online as supplemental

digital content.

SUBMISSION OF MANUSCRIPTS

General information.

• Manuscripts should be submitted electronically via this link: http://hrp.edmgr.com

• Revised manuscripts should be submitted in two forms: one with changes tracked in Word, and one “clean”

version with changes saved.

• Should you experience technical difficulties with this electronic submission process, please contact our

Communications Editor, Dawn Sugarman, PhD, at: [email protected] or 617-855-3650.

Consideration of proposed manuscripts. Authors considering a topic for submission to the Harvard Review of

Psychiatry are encouraged to submit a one-page description of the proposed manuscript. Proposals should include

the title and author(s), a brief outline, and a description of the submission’s clinical relevance. They should be sent

by email to our Communications Editor, Dawn Sugarman, PhD, at: dsugarm[email protected].edu

Checking for plagiarism, duplicate publication, and text recycling. Manuscripts submitted to the Harvard

Review of Psychiatry must represent original material that has not been published previously and that is not being

considered for publication elsewhere. In addition, each manuscript is screened by specialized software for content

that has been previously published (in print or online). It is expected that manuscripts are written in such a way that

does not recycle previously published text (e.g., self-plagiarism). We reserve the right to inform authors' institutions

or employers about suspected plagiarism detected either before or after publication.

Peer review. All manuscripts are initially evaluated by the Editorial Board. The Board may reject manuscripts

without further review, or send manuscripts out for peer review. The Editors notify the corresponding author when a

decision regarding acceptance has been made. Accepted manuscripts and letters are edited for clarity and for

conformity to the Review’s style. The journal uses a masked reviewing system. Therefore, authors should submit the

title page and manuscript as separate files. All identifying information (authors’ names, degrees, and affiliations,

plus acknowledgments), along with information concerning potential conflict of interests (see below under

“Declaration of interest”) should be included in the title page file but omitted from the manuscript file. Authors

should make every effort to ensure that the manuscript text file does not contain clues to their identities.

We require that all manuscripts be written in standard (fluent) English. If necessary, please have your work reviewed

and edited by a fluent English speaker in your environment. Alternatively, you may (at your expense) use a

professional language-editing service. Please see our website for more information about this option:

http://journals.lww.com/hrpjournal/_layouts/1033/oaks.journals/editservices.aspx

Social media. We may post a tweet about your article if it is accepted. You can follow Harvard Review of

Psychiatry on Twitter @HarvardRevPsych

Publication fees. There are no publication fees for authors, with the exception of articles containing color photos

and illustrations (see “Figures and illustrations” section).

Letters of permission to reproduce previously published material. All material reproduced intact or modified

from previously published or copyrighted material must be accompanied by a letter of permission from the original

author and copyright holder. All such material should also provide a full credit line (e.g., in the figure or table

legend) acknowledging the original source. The credit line should be worded according to the copyright holder’s

specifications.

Transfer of copyright and disclosure of commercial interests. Each author must complete and submit the

journal’s copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest

based on the recommendations of the International Committee of Medical Journal Editors, “Uniform Requirements

for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html). A copy of the form is made

available to the submitting author within the Editorial Manager submission process. Co-authors will

automatically receive an Email with instructions on completing the form upon submission.

Declaration of interest. The journal’s copyright transfer agreement includes a section on the disclosure of potential

conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors,

“Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html).

All authors must disclose all possible conflicts of interest on the title page of the manuscript, including any financial

and personal relationships with other people, organizations, or companies that could inappropriately influence (bias)

their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial

interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies,

employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or

patent applications or travel grants) that may affect the conduct or reporting of the work submitted. Additionally, any

financial associations involving a spouse or partner or children must be disclosed as well.

All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential

conflict of interest, authors should err on the side of full disclosure. Authors must state, consultant, institutional and

other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also

be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant

conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading

“Conflicts of Interest and Source of Funding:” For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently

receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the

CME organizers for Company A. For the remaining authors none were declared.

Information about such relationships must be stated at the time of submission and included on the title page (as

indicated above). This information about potential conflicts (or lack of them) may be made available to reviewers

and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared with respect to any particular article, the following statement will be appended to the end of

the article’s main text:

Conflicts of Interest and Source of Funding: The authors report no conflicts of interest. The authors alone are

responsible for the content and writing of the article.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt

transparency such that readers can make objective judgments on conclusions drawn.

OPEN ACCESS

LWW’s hybrid open access option is offered to authors whose articles have been accepted for publication. With this

choice, articles are made freely available online immediately upon publication. Authors may take advantage of the

open access option at the point of acceptance to ensure that this choice has no influence on the peer review and

acceptance process. These articles are subject to the journal’s standard peer-review process and will be accepted or

rejected based on their own merit.

Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access

to their published article to readers globally, immediately upon publication. The article processing charge for

Harvard Review of Psychiatry is $2,400. The article processing charge for authors funded by the Research

Councils UK (RCUK) is $2,850. The publication fee is charged on acceptance of the article and should be paid

within 30 days by credit card by the author, funding agency or institution. Payment must be received in full for the

article to be published open access. Any additional standard publication charges, such as for color images, will also

apply.

Authors retain copyright. Authors retain their copyright for all articles they opt to publish open access. Authors

grant LWW a license to publish the article and identify itself as the original publisher.

Creative Commons license. Articles opting for open access will be freely available to read, download and share

from the time of publication. Articles are published under the terms of the Creative Commons License Attribution-

NonCommerical No Derivative 3.0 which allows readers to disseminate and reuse the article, as well as share and

reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works

without specific permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-nc-nd/3.0.

Compliance with NIH, RCUK and other research funding agency accessibility requirements.

A number of research funding agencies now require or request authors to submit the post-print (the article after peer

review and acceptance but not the final published article) to a repository that is accessible online by all without

charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require

deposit and transmits the post-print of an article based on research funded in whole or in part by the National

Institutes of Health, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised

access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access

option will have their final published article deposited into PubMed Central.

RCUK funded authors can choose to publish their paper as open access with the payment of an article process

charge, or opt for their accepted manuscript to be deposited (green route) into PMC with an embargo.

With both the gold and green open access options, the author will continue to sign the Copyright Transfer

Agreement (CTA) as it provides the mechanism for LWW to ensure that the author is fully compliant with the

requirements. After signature of the CTA, the author will then sign a License to Publish where they will then own

the copyright.

It is the responsibility of the author to inform the Editorial Office and/or LWW that they have RCUK funding. LWW

will not be held responsible for retroactive deposits to PMC if the author has not completed the proper forms.

FAQ for open access. http://links.lww.com/LWW-ES/A48

PREPARATION OF MANUSCRIPTS

On-line manuscript submission. All manuscripts must be submitted online via Editorial Manager™, at

http://hrp.edmgr.com

First-time users. Please click the Register button on the Editorial Manager home page (http://hrp.edmgr.com). Enter

the requested information to complete your registration. Upon successful registration, an email containing your user

name and password will be sent to you. Please be sure to enter your email address correctly; if an error has been

made or an incorrect email address has been provided, you will not receive this notification.

Note: If you have already received an email containing your User ID and password, or if you are already

registered, do not register again. You may log in to the site using the information previously provided to you.

You may access your Author, Reviewer, and/or Editor accounts with the same log-in information.

Authors. Click the log-in button on the Editorial Manager home page, enter your username and password, and

click on Author Login. Click on the Submit Manuscript link to begin the submission process. Be sure to prepare

your manuscript according to the requirements laid out in these author instructions. Following submission to the

journal office, you will be able to track the progress of your manuscript through the system.

If you experience any problems with Editorial Manager or have any questions, please contact our

Communications Editor, Dawn Sugarman, PhD, at: [email protected] or 617-855-3650.

General information. Manuscript and other requirements conform to the “Uniform Requirements for Manuscripts

Submitted to Biomedical Journals” established by the International Committee of Medical Journal Editors (N Engl J

Med 1991;324:424–8). Submitting the materials in the correct format will expedite the review process and prevent

unnecessary delay in publication. All major parts of the manuscript (title page, abstract, text, acknowledgments,

references, tables, and legends for illustrations) must be typed double-spaced in 12-point type. All four margins must

be at least 1 inch, and the right-hand margin should be unjustified (ragged). The manuscript file should be arranged

in the following order: title (without author names), abstract and key words, text, references. All pages must be

numbered, beginning with the title. If a running head is used, it must not include authors’ names.

Cover letter. The cover letter should include: (1) the article title, which should be concise but informative; (2) the

authors’ first and last names, academic degrees, and primary institutional affiliation(s); (3) the full address, telephone

number, and fax number of the author who is to receive reprint requests (email address optional); (4)

acknowledgments, including grant support (granting agency and grant number) and drug company support of any

kind; (5) the name, location, and date of any meetings at which the submitted manuscript has been presented; (6) a

statement indicating that the manuscript represents original material, has not been previously published, and is not

under consideration for publication elsewhere; and (7) a statement that all authors have read and approved the final

submitted version of this manuscript.

Title page. A full title page should be submitted as a separate file and should include: authors’ names, degrees, and

affiliations. Please also include a word count (excluding references, tables, and figures), the number of tables, the

number of figures, and the number of references. Acknowledgments and information concerning potential conflict of

interests should be included in the title page and NOT in the manuscript file.

Abstract. The abstract should not exceed 250 words. Please provide five keywords or phrases to assist indexers. The

words or phrases should preferably be taken from the MeSH headings used for indexing articles in PubMed.

Text. For review articles, the text should begin with an introductory section, include a brief description of the

methods used to select the articles reviewed (database, terms searched, limitations imposed), and end with a

discussion section. The use of subheadings is encouraged.

Tables and figures. Figures, figure legends, and tables should be uploaded as separate documents. Start each section

on a new page.

Abbreviations. Abbreviations may be used but (1) should be employed only for terms appearing repeatedly

throughout the manuscript, (2) must be spelled out the first time they appear in the text, and (3) must be consistent

throughout the manuscript. Abbreviations may not be used in the title and should be avoided, if possible, in the

abstract. Employ standard abbreviations if they exist.

Drug names. Generic rather than trade names of drugs should be used, although trade names may be mentioned in

parentheses in the first text reference to the drug.

Form and numbering of references. References need to be identified in the text, tables, legends (of figures), and

text boxes by Arabic numbers as superscripts. References are numbered in the order in which they first occur,

whether in main text, tables, legends (of figures), or text boxes (NB: for more on numbering references in tables and

in other elements, see separate sections below). The same order (rather than, say, alphabetical order) should be used

in the reference list. Once a reference takes on a number, it keeps that number for all future occurrences in the

article. Author-date citations are unacceptable, both in the text and in the reference list itself. References should not

be entered using a word processor’s footnote or endnote function. If a program such as Endnote or Reference

Manager is not used, superscript numbers will need to be entered in the text, correlated with the numbering of the

reference list. The style of references should follow that of the examples below, using the abbreviated journal titles

that are used in PubMed. In the reference list, all authors should be given, separated simply by commas (no and’s or

&’s), unless the number exceeds six, in which case the first three authors are given, followed by “et al.” (thereby

becoming, e.g., Smith AA, Jones BB, Collins CC, et al.)

Reference examples:

1. Black DW, Noyes R Jr, Goldstein RB, Blum N. A family study of obsessive-compulsive disorder. Arch Gen

Psychiatry 1992;49:362–8.

2. Mavissakalian M. Differential efficacy between tricyclic antidepressants and behavior therapy of panic

disorder. In: Ballenger JC, ed. Clinical aspects of panic disorder. New York: Wiley-Liss, 1990:211–8.

3. Talbott JA, Hales RE, Yudofsky SC, eds. The American Psychiatric Press textbook of psychiatry.

Washington, DC: American Psychiatric Press, 1988.

Unpublished observations, unpublished manuscripts, and personal communications cannot be included in the

reference list but can be inserted in parentheses in the text. Articles in press (that is, accepted for publication but not

yet published) may be cited in the reference list, marked with the abbreviated name of the publication included

(followed by “(in press).” Papers presented at scientific meetings can also be included in the reference list (using the

author’s name, title of paper, name and location of scientific meeting, and the month and year of the meeting).

Duplicate references should be eliminated.

Our house style is available as an output style under Endnote; it may need to be separately downloaded from the

Endnote website. If manuscripts have been prepared using either Endnote or Reference Manager, the program

information should be included with the submitted document. If a manuscript is later accepted for publication in the

Review, the Endnote or Reference Manager programming may prove useful during the final editing process (e.g., if

references are added, subtracted, or reordered, all of which happen fairly frequently).

No footnotes or endnotes are permitted except under exceptional circumstances (where, for example, including

certain vital material, especially of a background character, would interfere too much with the flow of the text). In

that situation, either a brief footnote or a longer text box may be used.

TABLES, FIGURES, ILLUSTRATIONS, AND TEXT BOXES

Tables. Tables should not duplicate text material. They should be cited in the text (e.g., “See Table 2”) and

numbered sequentially in the order that they are mentioned in the text. Tables should be composed and formatted

using either Microsoft Excel or, preferably, the table function within Microsoft Word. NB: Tables formatted into

columns and rows using spaces, tabs, and carriage returns (“Enter” on computer keyboards) are unacceptable and

need to be returned to authors for reformatting. A model table is available for downloading on the Review’s website,

listed with the downloadable Instructions for Authors.

Within tables, studies should be cited in chronological order unless there are different categories of studies within a

table (e.g., different categories of antidepressants). In that case, the studies should be listed in chronological order

within each category.

Each study should be described as follows: Last name(s) of author(s) // year of publication // reference number. For

one author, list that name. For two authors, list both names. For three or more authors, list the name of first author

followed by “et al.”

Hence, for example, if the last reference mentioned in the main text was 16, if Jones and Smith (2001) has

previously been mentioned in the text and given the number 9, and if the other two references are first mentioned in

the table, then the following studies should appear in the table as follows (and in the order indicated):

Smith (1998)

Jones & Smith (2001)

Smith et al. (2005)

If the last new reference mentioned in a table is, for example, numbered 22, the next new reference mentioned in the

text will be numbered 23.

Finally, all abbreviations in tables need to be listed at the end of the table in alphabetical order (e.g.: CBT, cognitive-

behavioral therapy; PT, physical therapy; SSRI, selective serotonin reuptake inhibitor), but note that only standard

expressions or words should be abbreviated (e.g., PTSD or SSRI). Phrases like “not demonstrated to be effective”

should not be abbreviated (e.g., as NDTBE). The goal is to maintain readability; unfamiliar or awkward

abbreviations may save space, but they make tables, which are inherently difficult to read, even more so.

Figures and illustrations. Figures and illustrations should not duplicate text material. They should be cited in the

text (e.g., “See Figure 3”) and numbered sequentially in the order that they are mentioned in the text. When digital

images are submitted, the files should comply with the following guidelines: (1) 300 dpi or higher, (2) sized to fit on

a journal page, (3) EPS, JPG, PSD, or TIFF format only, and (4) submitted as separate files, not embedded in text

files. Because figures and illustrations that include text generally need some linguistic editing to comply with house

style, figures and illustrations should also be submitted, or at least be available during the editing process, in a form

that permits editing. Color photographs and illustrations will be considered for publication; however, the author will

be required to bear the full cost involved in their printing and publication. The charge for the first illustration with

color is $750 and $150 for each additional piece within the same article and may be adjusted by the Publisher at the

Publisher’s discretion to cover increases in the Publisher’s production costs. The publisher has the right to refuse

publication of color prints deemed unacceptable.

• Art should be created/scanned and saved as one of the accepted file types: TIFF (tagged image file format),

EPS (encapsulated PostScript), PDF (Portable Document Format), JPEG, PPT (PowerPoint), or DOC (Word

document).

• Line art must be vector or have a resolution of at least 1200 dpi (dots per inch),

• Electronic photographs—radiographs, CT scans, and so on—and scanned images must have a resolution of

at least 300 dpi.

• Photographs containing text must have a resolution of at least 600 dpi.

• If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the

files.

• Cite figures consecutively on the site, and number them in the order in which they are discussed. For

additional assistance, please refer to the journal’s Creating Digital Artwork file at

http://links.lww.com/ES/A42.

Digital Artwork Guideline Checklist. Here are the basics to have in place before submitting your digital art to the

Harvard Review of Psychiatry:

• Artwork is created as the actual size (or slightly larger) it will appear in the journal. (To get an idea of the

size images should be when they print, study a copy of the journal to which you wish to submit. Measure the

artwork typically shown and scale your image to match.)

• Crop out any white or black space surrounding the image.

• Text in any figure must use a simple, sans serif font, preferably Calibri.

• Each figure must be saved and submitted as a separate file.

• Figures should not be embedded in the manuscript text file.

o For multi-panel or composite figures only: Any figure with multiple parts should be sent as one file

with each part labeled the way it is to appear in print.

• Cite figures consecutively in your manuscript.

• Number figures in the figure legend in the order in which they are discussed.

• Upload figures consecutively to the Editorial Manager website and number figures consecutively in the

Description box during upload.

Legends. Titles, detailed descriptions of figures and illustrations, and explanations of any superscript letters or

abbreviations used in figures belong in the legend, not on the figures or illustrations themselves. Legends should be

double-spaced and submitted as separate files.

Text boxes. Nontabular information to supplement the text can be included in text boxes.

Numbering of references in tables, legends (of figures and illustrations), and text boxes, including

Supplemental Digital Content (SDC; see below). References in tables, legends, text boxes, and SDC are deemed to

have their first occurrence at exactly the point in the main text where the table, figure, illustration, text box, or SDC

is first mentioned (e.g., “See Table 1.”). If one of these references has already been given a number, then it keeps

that previously assigned number. If the reference has not been previously mentioned, then it takes a number based on

its order of mention in the table, legend, text box, or SDC, and keeps it if that reference is later mentioned in the

article.

One way of ensuring that references in tables, legends, text boxes, and SDC are correctly numbered is to place those

elements in the document at exactly the point (even in the middle of a paragraph, breaking it into two) where they

are first mentioned, and to number the references accordingly. If Endnote or Reference Manager is being used, then

the numbering will done automatically and correctly as long as the element in question is placed immediately after

the first reference to it in the text.

Supplemental Digital Content (SDC). Authors may submit SDC that enhances their article's text to be considered

for online-only posting. SDC, with references numbered as indicated in the two preceding paragraphs, may include

standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission

process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an

article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in

the call-out within the article. SDC files are not copyedited by LWW staff; they will be presented digitally as

submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.

SDC Call-Outs Supplemental Digital Content must be cited consecutively, by file type, in the text of the submitted

manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled,

by file type, as “Supplemental Audio [or Figure, Table, etc.] 1 [or any higher number, in sequence for that specific

file type],” and provide a description of the supplemental content. All descriptive text should be included in the call-

out as it will not appear elsewhere in the article.

Example:

We performed many tests on the degrees of flexibility in the elbow (see Supplemental Video 1, which

demonstrates elbow flexibility) and found our results inconclusive.

List of Supplemental Digital Content A listing of Supplemental Digital Content must be submitted at the end of the

manuscript file. Include the SDC file type and number. This text will be removed by our production staff and not be

published.

Example: Supplemental Audio 1.wmv

SDC File Requirements All acceptable file types are permissible up to 10 MB. For audio or video files greater than

10 MB, authors should first query the journal office for approval. For a list of all available file types and detailed

instructions, please visit http://links.lww.com/A142.

Acceptable SDC File Types:

Text files and

Tables

Any format or file type is acceptable

Common file extensions include: .doc, .xls, .pdf, .pptx

Figures and

Images

.tif, .eps, .ppt, .pptx, .doc, .docx, .jpg, .pdf, .gif*

*Only acceptable for online-only figures. Figures intended to be printed in the journal may not

be submitted using the .gif file type.

Audio

.mp3, .wma, .wav

Video

.wmv, .swf, .flv, .mov, .qt, .mpg, .mpeg, .mp4

OTHER REQUIREMENTS

Affirmation of authorship. All persons designated as authors must qualify for authorship. Authorship credit should

be based only on substantial contributions to (1) conception and design, or analysis and interpretation of data, (2)

drafting the article or revising it critically for important intellectual content, and (3) final approval of the submitted

version. All three conditions must be met. General supervision of the research group or participation solely in the

acquisition of funding or the collection of data does not justify authorship. Each author should have participated

sufficiently in the work to take public responsibility for the content, and the authors are responsible for all statements

made in their work, including any changes made by the editorial office that have been approved by the

corresponding author. Individuals who contribute to the manuscript but who do not meet authorship requirements

may be cited in an acknowledgment if their permission for such citation is obtained. As noted earlier, the cover letter

must state that all authors have read and approved the final version of the manuscript.

Prior and duplicate publication. When a manuscript is submitted, the cover letter must include a statement

indicating that the manuscript represents original material, has not been previously published, and is not under

consideration for publication elsewhere. Except for abstracts of less than 400 words, any form of publication,

including components of symposia, proceedings, books or book chapters, or reports of any kind, constitutes prior

publication. Press reports of meetings will not usually be considered a breach of this rule, but such reports should not

be amplified with additional data or with copies of tables or illustrations. Authors should notify the Editors if the

manuscript contains data that have been used in published articles, in articles that are in press, or in manuscripts that

have been or will soon be submitted for publication. The authors should include copies of such material with the

submitted manuscript and should explain the differences between the manuscripts.

Reproduction. Except for copyright, other proprietary rights related to the Work (e.g., patent or other rights to any

process or procedure) shall be retained by the author. Authors will be allowed to use their articles published in the

Harvard Review of Psychiatry for educational, non-commercial purposes, including without limitation for

distribution to students enrolled in a course at the author’s institution or to attendees at a presentation by the author.

Non-commercial use specifically excludes any sale of the Work or any portion thereof for money, even if the sale

does not result in a profit by the seller or if the sale is by a non-profit. If an author wishes to make any use of an

article for which permission is required, the Author must request permission for such use through the RightsLink

link via the journal’s website or apply for permission through the journal’s publisher, Lippincott Williams &

Wilkins.

Informed consent. When applicable, manuscripts must be accompanied by a statement that informed consent was

obtained from human subjects. Authors should protect patient anonymity by avoiding the use of patients’ names or

initials, hospital number, or other identifying information. All Clinical Challenges must be accompanied by the

proper informed consent document(s), as must other article types that contain information from actual cases.

Minor Assent Form (PDF)

Adult Consent Form (PDF)

Adult Consent Form (Spanish) (PDF)

Parent or Guardian of Minor Consent Form (PDF)

Reprints. The Publisher shall provide the opportunity for contributors to buy offprints or reprints of their articles, as

well as complete copies of the issue, at the page-proof stage of production.